About the Journal

The Global Journal of Pharmacology and Therapeutics (GJPT) is an international, peer-reviewed, open-access journal dedicated to publishing high-quality research that spans the entire field of pharmacology and clinical therapeutics. The journal serves as a global platform connecting laboratory discoveries with clinical applications, fostering innovation in drug development, therapeutic strategies, and patient care.

Aims & Scope

The aim of GJPT is to advance scientific knowledge by publishing cutting-edge studies in both experimental pharmacology and clinical therapeutics. The journal seeks to bridge the gap between drug discovery and bedside medicine by welcoming contributions that highlight mechanisms of drug action, novel therapeutic agents, pharmacokinetics, safety profiles, and patient outcomes.

We encourage submissions from all areas of pharmacology, including preclinical investigations, translational studies, clinical trials, and pharmacovigilance research.

Journal Scope

• Basic & Experimental Pharmacology – molecular mechanisms, receptor studies, pharmacodynamics, laboratory models.
• Clinical Pharmacology & Therapeutics – clinical trials, drug development, therapeutic strategies, dosing optimization.
• Neuropharmacology & Psychopharmacology – drugs acting on the nervous system, psychiatric medications, addiction research.
• Cardiovascular & Renal Pharmacology – antihypertensives, cardioprotective drugs, diuretics, and therapies for renal diseases.
• Endocrine & Metabolic Pharmacology – diabetes and obesity treatments, hormonal drugs, reproductive pharmacology.
• Immunopharmacology & Biologics – immunotherapies, monoclonal antibodies, vaccines, and biologically derived therapies.
• Oncology & Chemotherapy – anticancer agents, targeted therapies, immuno-oncology, and combination regimens.
• Toxicology & Pharmacovigilance – drug safety studies, adverse event reporting, and toxicological investigations.
• Pharmacogenomics & Personalized Medicine – gene–drug interactions, precision medicine, biomarker-guided treatments.
• Case Reports & Clinical Observations – rare or novel therapeutic outcomes, unusual adverse reactions, and clinical insights.

Manuscript Turn Around Time

• In-House Review: 1-2 days
• External Peer Review: 2 weeks (initial editorial decision approximately 2 weeks after submission)
• Revision time: 1-2 weeks
• Formal Publication: within a week after being accepted

Total time from submission to publication is approximately 27-31 days.